Skip to main content
. 2017 May 5;12(5):817–824. doi: 10.2215/CJN.10701016

Table 2.

Donor, recipient, and organ characteristics verification panel

Parameter IF (n=13) DGF (n=27) P Value
Donor
 Age, yr 56.0 [50.0–59.0] 58.0 [50.8–62.3] 0.41
 BMI, kg/m2 25.1 (4.6) 27.0 (4.4) 0.20
 Hypertension, % 15.4 (n=2) 33.3 (n=9) 0.17
 Diabetes, % 0 (n=0) 7.4 (n=2) 0.33
 Creatinine, µM 62.2 (23.5) 63.1 (21.8) 0.98
 KDRI 1.22 (0.38) 1.32 (0.30) 0.39
 Cause of death: anoxia, % 61.5 (n=8) 44.4 (n=12) 0.32
Recipient
 Age, yr 63.0 [51–68] 65.5 [52.3–72.0] 0.77
 BMI, kg/m2 25.6 (4.3) 28.3 (4.5) 0.09
 Men, % 69.2 (n=9) 63.0 (n=17) 0.71
 Peak PRA, % 7.3 (15.0) 6.1 (10.2) 0.76
 Dialysis duration, mo 13.0 [2.7–18.0] 31.5 [24.25–51.25] 0.01
 Prior transplants, % 15.4 (n=2) 18.5 (n=5) 0.81
 Dialysis type: HD, % 84.6 (n=11) 77.8 (n=21) 0.62
 Diabetes, % 23.1 (n=3) 25.3 (n=7) 0.85
Organ
 HLA mismatches 4 [3–4] 3.5 [3–4] 0.37
 CIT, h 11.1 [9.8–14.7] 13.6 [10.8–17.2] 0.56
 WIT, min 25.0 [20.0–28.0] 26.6 [21.8–31.5] 0.55

Clinical parameters relevant for calculation of KDRI and DGF risk score of the 40 samples used for verification. SDs between brackets; interquartile ranges between square brackets. IF, immediate function; DGF, delayed graft function; BMI, body mass index; KDRI, kidney donor risk index; PRA, panel-reactive antibodies; HD, hemodialysis; CIT, cold ischemia time; WIT, warm ischemia time.